Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda (Q34300246)

1 August 2017

Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda (English)

1 reference

1 August 2017

0 references

0 references

1 reference

7

Karl E Anderson

1 reference

1 August 2017

Ashwani K Singal

1

1 reference

1 August 2017

Csilla Kormos-Hallberg

2

1 reference

1 August 2017

Chul Lee

3

1 reference

1 August 2017

Vaithamanithi M Sadagoparamanujam

4

1 reference

1 August 2017

James J Grady

5

1 reference

1 August 2017

Daniel H Freeman

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

14 September 2012

1 reference

Clinical Gastroenterology and Hepatology

1 August 2017

1 reference

1 August 2017

10

1 reference

1 August 2017

12

1 reference

1 August 2017

1402-1409

1 reference

CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Associations among behavior-related susceptibility factors in porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Recommendations for the diagnosis and treatment of the acute porphyrias

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Iron as a co-morbid factor in nonhemochromatotic liver disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Iron overload in porphyria cutanea tarda.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Treatment of porphyria cutanea tarda with chloroquine and its effect on associated liver disease: retrospective analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Ophthalmologic considerations in using antimalarials in the United States

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Treatment of porphyria cutanea tarda by the effect of chloroquine on the liver

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Hydroxychloroquine treatment of porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Chloroquine in treatment of porphyria cutanea tarda. Long-term efficacy of combined phlebotomy and high-dose chloroquine therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Effects of phlebotomy on urinary porphyrin pattern and liver histology in patients with porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Low-dose oral chloroquine in the treatment of porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Biochemical effects of chloroquine therapy in porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

The treatment of porphyria cutanea tarda by venesection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Treatment of porphyria cutanea tarda with chloroquine.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

The Molecular Basis of the Action of Chloroquine in Porphyria Cutanea Tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

The therapeutic effect of chloroquine. Hepatic recovery in porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Influence of chloroquine on the porphyrin metabolism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

High-dose hydroxychloroquine treatment of porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Chloroquine in the treatment of porphyria cutanea tarda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Measurement of liver iron content by magnetic resonance imaging in 20 patients with overt porphyria cutanea tarda before phlebotomy therapy: a prospective study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Porphyria cutanea tarda: effects and risk factors for hepatotoxicity from high-dose chloroquine treatment

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

EFFECTS OF CHLOROQUINE ON PATIENTS WITH CUTANEOUS PORPHYRIA OF THE "SYMPTOMATIC" TYPE.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501544

Interval estimation for the difference between independent proportions: comparison of eleven methods

28 October 2018

1 reference

12 December 2020

Effect of an oral iron chelator or iron-deficient diets on uroporphyria in a murine model of porphyria cutanea tarda

1 reference

12 December 2020

1 reference

12 December 2020

Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda

1 reference

12 December 2020

The effect of venesection therapy on liver tissue in porphyria cutanea tarda

1 reference

12 December 2020

Direct spectrofluorometry of diluted erythrocytes and plasma: a rapid diagnostic method in primary and secondary porphyrinemias

1 reference

12 December 2020

Treatment of porphyria cutanea tarda by phlebotomy

1 reference

12 December 2020

Phlebotomy treatment in porphyria cutanea tarda combined with beta-thalassaemia

1 reference

12 December 2020

Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda

1 reference

12 December 2020

Plasma ferritin levels as a guide to the treatment of porphyria cutanea tarda by venesection

1 reference

12 December 2020

Porphyria cutanea tarda. A study of the effect of phlebotomy

1 reference

12 December 2020

Iron storage in porphyria cutanea tarda

1 reference

12 December 2020

The effect of phlebotomy therapy in porphyria cutanea tarda. Its relation to the phlebotomy-induced reduction of iron stores

1 reference

12 December 2020

Delta-aminolaevulinic acid in acute porphyria

1 reference

12 December 2020

10.1016/J.CGH.2012.08.038

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference